U.S., Sept. 26 -- ClinicalTrials.gov registry received information related to the study (NCT07193459) titled 'Study to Evaluate HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus' on Sept. 01.
Brief Summary: This is a multicenter, randomized, double-blind, placebo-controlled, parallel-group study, which aims to provide data on the efficacy and safety of HDM1002 tablets in adults with type 2 diabetes mellitus (T2DM) inadequately controlled with diet and exercise only
Study Start Date: Aug. 12
Study Type: INTERVENTIONAL
Condition:
Type 2 Diabetes
Intervention:
DRUG: HDM1002 200 mg
HDM1002 tablets, 200 mg once daily
DRUG: HDM1002 400 mg
HDM1002 tablets, 400 mg once daily
DRUG: Placebo
Placebo tablets, once daily
Recruitment S...